United Kingdom (UK) Sustainable Tourism Market Summary, Competitive Analysis and Forecast to 2027

Summary


MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment, and the personalized treatment of patients. The company’s product portfolio includes ConfirmMDx, an epigenetic assay that detects the epigenetic effect of cancer; SelectMDx, a liquid biopsy assay for prostate cancer. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in the Netherlands, Belgium, and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MDxHealth SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the leading companies’ ESG initiatives?
7.3. How is technology used to enable sustainability?
7.4. Are there any other notable players in the sustainable tourism market?
8 Company Profiles
8.1. Accor SA
8.2. International Consolidated Airlines Group SA
8.3. Booking Holdings Inc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related GlobalData research
About GlobalData
List of Tables
Table 1: United Kingdom sustainable tourism market value: $ million, 2017–22
Table 2: United Kingdom sustainable tourism market category segmentation: % share, by value, 2017–2022
Table 3: United Kingdom sustainable tourism market category segmentation: $ million, 2017-2022
Table 4: United Kingdom sustainable tourism market geography segmentation: $ million, 2022
Table 5: United Kingdom sustainable tourism market value forecast: $ million, 2022–27
Table 6: Accor SA: key facts
Table 7: Accor SA: annual financial ratios
Table 8: Accor SA: key employees
Table 9: Accor SA: key employees Continued
Table 10: International Consolidated Airlines Group SA: key facts
Table 11: International Consolidated Airlines Group SA: annual financial ratios
Table 12: International Consolidated Airlines Group SA: key employees
Table 13: Booking Holdings Inc: key facts
Table 14: Booking Holdings Inc: annual financial ratios
Table 15: Booking Holdings Inc: key employees
Table 16: United Kingdom size of population (million), 2018–22
Table 17: United Kingdom gdp (constant 2005 prices, $ billion), 2018–22
Table 18: United Kingdom gdp (current prices, $ billion), 2018–22
Table 19: United Kingdom inflation, 2018–22
Table 20: United Kingdom consumer price index (absolute), 2018–22
Table 21: United Kingdom exchange rate, 2018–22
List of Figures
Figure 1: United Kingdom sustainable tourism market value: $ million, 2017–22
Figure 2: United Kingdom sustainable tourism market category segmentation: $ million, 2017-2022
Figure 3: United Kingdom sustainable tourism market geography segmentation: % share, by value, 2022
Figure 4: United Kingdom sustainable tourism market value forecast: $ million, 2022–27
Figure 5: Forces driving competition in the sustainable tourism market in the United Kingdom, 2022
Figure 6: Drivers of buyer power in the sustainable tourism market in the United Kingdom, 2022
Figure 7: Drivers of supplier power in the sustainable tourism market in the United Kingdom, 2022
Figure 8: Factors influencing the likelihood of new entrants in the sustainable tourism market in the United Kingdom, 2022
Figure 9: Factors influencing the threat of substitutes in the sustainable tourism market in the United Kingdom, 2022
Figure 10: Drivers of degree of rivalry in the sustainable tourism market in the United Kingdom, 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings